Tag: portfolio valuation

NBPE – Net Asset Value(s)

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

ARGAN: H1 2025 – Strong growth and 2025 targets confirmed

Half-year results – Neuilly-sur-Seine, Thursday July 17, 2025 – 5.45 pm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsPortfolio valuation

McDONALD’S ANNOUNCES QUARTERLY CASH DIVIDEND

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

ALTO NEUROSCIENCE, INC. (NYSE: ANRO) INVESTOR ALERT Investors With Large Losses in Alto Neuroscience, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Tag: portfolio valuation

NBPE – Net Asset Value(s)

ARGAN: H1 2025 – Strong growth and 2025 targets confirmed

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us